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1608 Development of biologic coronary artery bypass grafting in a rabbit model:
Revival of a classic concept with modern biotechnology
Koji Ueyama, MD, Gao Bing, MD, Yasuhiko Tabata, PhD, Makoto Ozeki, BS, Kazuhiko Doi,
MD, Kazunobu Nishimura, MD, PhD, Hisayoshi Suma, MD, PhD, and Masashi Komeda, MD,
PhD, Kyoto and Kanagawa, Japan
Bypass from the gastroepiploic artery to coronary arteries was achieved without surgical
anastomosis by slow release of basic fibroblast growth factor in a rabbit model of acute MI.
This new approach revives a classic concept with modern biotechnology and has potential to
offer revascularization for coronary artery disease without treatment options.
1616 Hemodynamic and clinical outcomes with the Biocor valve in the aortic
position: An 8-year experience
Tomaso Bottio, MD, Giulio Rizzoli, MD, Gaetano Thiene, MD, Georgios Nesseris, MD,
Dino Casarotto, MD, and Gino Gerosa, MD, Padua, Italy
Analyzing the 8-year survival, prosthetic complications, and hemodynamics of patients who
received the Biocor valve in the aortic position, we observed a high freedom from valve-related
complications comparable with that of other tissue valves and a low rate of reoperation caused
by structural valve deterioration.
1624 Beating heart revascularization with or without cardiopulmonary bypass:
Evaluation of inflammatory response in a prospective randomized study
Innes Y. P. Wan, FRCSEd, Ahmed A. Arifi, MD, FRCS, Song Wan, MD, FRCS,
Johnson H. Y. Yip, MPhil, Alan D. L. Sihoe, MRCSEd, K. H. Thung, FRCSEd,
Eric M. C. Wong, MSc, and Anthony P. C. Yim, MD, FRCS, Hong Kong, China
We compared the inflammatory response of patients undergoing on-pump beating heart and
off-pump coronary artery bypass surgery. We concluded that the use of cardiopulmonary
bypass even without cardioplegia and aortic crossclamping could trigger intense inflammatory
response.
1632 Clinical and angiographic results after mechanical connection for distal
anastomosis in coronary surgery
Thierry Carrel, MD, Lars Englberger, MD, Dorothee Keller, RN, Stephan Windecker, MD,
Bernhard Meier, MD, and Friedrich Eckstein, MD, Berne, Switzerland
We investigated a distal stainless steel coronary sutureless connector system (St Jude Medical,
Inc). Thirty-two patients received 1 distal anastomosis with this investigational device. Four
connectors had to be removed because of minor leakage. No adverse cardiac events occurred in
the remaining patients. All patients were free of angina and had normal exercise ECGs at 6 and
12 months of follow-up. Angiograms were available in 21 patients: 17 anastomoses were
patent, and 4 were occluded. This promising device may give a significant boost to less
invasive coronary revascularization.
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